Established to develop high-potency pharmaceutical dosage forms that are limited in production or cannot be manufactured in Türkiye, our R&D center is one of the cornerstones of our facility.

With our GMP-certified pilot production laboratory and more than 200 state-of-the-art equipment units, we possess one of the strongest oncology-focused R&D infrastructures in the Turkish pharmaceutical industry.

From patent research to product registration, we carry out all processes with a Quality by Design (QbD) approach, developing innovative treatments through scientific research.